ArticleLeukemia research2019

Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation.

Ryotaro Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.